Host-Microbe Interactions in Intestinal Health

The human intestine is colonised by a vast and diverse community of microorganisms whose collective activities are essential to digestion, barrier integrity and immune homeostasis. Commensal bacteria contribute to nutrient processing and generate metabolites such as short-chain fatty acids that regulate epithelial turnover and reinforce tight junctions. Epithelial cells respond to microbial signals by secreting antimicrobial peptides and mucins, thus maintaining a spatial barrier that prevents undue immune activation. Innate lymphoid cells and mucosal dendritic cells are educated by microbial cues to produce interleukins that tune inflammatory responses. Disruption of this finely balanced ecosystem—termed dysbiosis—can compromise barrier function, trigger chronic inflammation and underpin disorders ranging from inflammatory bowel disease to metabolic syndrome. Advances in organoid cultures, gnotobiotic models and high-resolution sequencing have begun to unravel the molecular dialogue between host and microbe, opening avenues for targeted interventions. Probiotics, postbiotic metabolites and dietary modulation offer practical strategies to restore homeostasis, underscoring the global significance of host-microbe interactions for intestinal health and beyond.

Research from Nature Portfolio

Recent studies have highlighted how specific commensals directly shape barrier function through metabolic cross-talk. One seminal investigation demonstrated that certain Lactobacillus strains convert dietary arginine into L-ornithine, which in turn boosts aryl hydrocarbon receptor ligand production by epithelial cells. This cascade enhances the activity of RORγt+ ILC3 cells to secrete IL-22, promoting goblet cell proliferation and mucin deposition. Such findings reveal a precise biochemical axis by which microbial metabolism sustains the mucosal layer and suggests postbiotic therapies to reinforce gut defence in disease settings.

Host-Microbe Interactions in Intestinal Health publication trend

The graph below shows the total number of articles in host-microbe interactions in intestinal health across all publications each year (not limited to Nature Index journals).

Technical terms

Tight junction: A protein complex between epithelial cells that regulates paracellular permeability and prevents unwanted passage of luminal contents.

Antimicrobial peptide: A small, host-derived protein that directly kills or inhibits microbial pathogens to maintain mucosal defence.

Mucosal barrier: The combined physical and chemical layers of mucus, epithelial cells and immune factors that protect underlying tissue from luminal microbes.

Short-chain fatty acid (SCFA): A microbial fermentation product of dietary fibres, including acetate, propionate and butyrate, which nourishes colonocytes and modulates immunity.

Innate lymphoid cell (ILC3): A subset of mucosal immune cell that produces IL-22 in response to microbial signals, promoting epithelial repair and barrier integrity.

References

1. Muramyl peptide blend ameliorates intestinal inflammation and barrier integrity in cell culture model. Gastroenterology (2024).
2. Reg3γ: current understanding and future therapeutic opportunities in metabolic disease. Experimental & Molecular Medicine (2023).
3. Intestinal Barrier in Human Health and Disease. International Journal of Environmental Research and Public Health (2021).
4. Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids. PLOS ONE (2016).
5. Lactobacillus maintains healthy gut mucosa by producing L-Ornithine. Communications Biology (2019).